NMPA Approval

Ceftriaxone Sodium for Injection

Approval Number

国药准字HC20181001

Company

台湾泛生制药厂股份有限公司

Registration Date

January 12, 2023

Previous Approval Numbers

HC20181001

Drug Information

Generic Name

注射用头孢曲松钠

Trade Name

泛生舒复

Brand Name

泛生舒复

Dosage Form

注射剂

Strength

1.0g（按C₁₈H₁₈N₈0₇S₃计）

Drug Type

化学药品

Registration Date

January 12, 2023

Expiry Date

January 11, 2028

Company Information

Applicant Company

Company Name

台湾泛生制药厂股份有限公司

Company Address

台湾省高雄市鸟松区大同路5-1号

Manufacturing Company

Company Name

panbiotic laboratories pabp branch

Company Address

台湾屏东县长治乡德和村园东一街10、12号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

注射用头孢曲松钠 - NMPA 批准文号 | MedPath

AI-Powered Research

Premium Access